Table of Content

1 INTRODUCTION 54
1.1 STUDY OBJECTIVES 54
1.2 MARKET DEFINITION 54
1.3 STUDY SCOPE 55
1.3.1 INCLUSIONS & EXCLUSIONS 55
1.3.2 MARKET SEGMENTATION AND REGIONAL SCOPE 56
1.3.3 YEARS CONSIDERED 57
1.3.4 CURRENCY CONSIDERED 57
1.4 STAKEHOLDERS 57
1.5 SUMMARY OF CHANGES 58
2 RESEARCH METHODOLOGY 59
2.1 RESEARCH DATA 59
2.1.1 SECONDARY DATA 60
2.1.1.1 Key data from secondary sources 61
2.1.2 PRIMARY DATA 61
2.1.2.1 Key data from primary sources 63
2.1.2.2 Key industry insights 64
2.2 MARKET ESTIMATION METHODOLOGY 64
2.2.1 GLOBAL MARKET ESTIMATION 65
2.2.2 SEGMENTAL MARKET SIZE ESTIMATION 68
2.3 MARKET GROWTH RATE PROJECTIONS 69
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 71
2.5 RESEARCH ASSUMPTIONS 72
2.6 RESEARCH LIMITATIONS 73
2.7 RISK ANALYSIS 73
3 EXECUTIVE SUMMARY 74
4 PREMIUM INSIGHTS 78
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN PHARMACEUTICAL FILTRATION MARKET 78
4.2 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY END USER AND COUNTRY, 2023 79
4.3 PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2023 80
4.4 PHARMACEUTICAL FILTRATION MARKET, BY END USER, 2023 80
4.5 PHARMACEUTICAL FILTRATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 81
?
5 MARKET OVERVIEW 82
5.1 INTRODUCTION 82
5.2 MARKET DYNAMICS 82
5.2.1 DRIVERS 84
5.2.1.1 Growing pharmaceutical industry 84
5.2.1.2 Rising R&D spending in pharmaceutical and biotechnology industries 85
5.2.1.3 Increasing adoption of single-use technologies 86
5.2.1.4 Increasing purity requirement in pharmaceutical and biotechnology manufacturing 87
5.2.1.5 Adoption of continuous manufacturing process 87
5.2.2 RESTRAINTS 88
5.2.2.1 Membrane fouling and breakage issues 88
5.2.2.2 High capital investments required for new production facilities 88
5.2.2.3 Technological limitations 88
5.2.3 OPPORTUNITIES 89
5.2.3.1 Growth opportunities in emerging economies 89
5.2.3.2 Advances in nanofiber technology 90
5.2.3.3 Growing need for high-efficiency filters for vaccine production 90
5.2.4 CHALLENGES 90
5.2.4.1 Increased cost and reduced speed and yield of filters 90
5.2.4.2 Survival of small players and new entrants 91
5.2.4.3 Stringent regulatory compliance 91
5.3 TECHNOLOGY ANALYSIS 92
5.3.1 KEY TECHNOLOGIES 92
5.3.1.1 Microfiltration 92
5.3.1.2 Ultrafiltration 92
5.3.1.3 Nanofiltration 93
5.3.2 COMPLEMENTARY TECHNOLOGIES 93
5.3.2.1 Single-Use Technology 93
5.3.2.2 Electrospun Microfibers 93
5.3.2.3 Photocatalytic Filtration 94
5.3.3 ADJACENT TECHNOLOGIES 94
5.3.3.1 Chromatography 94
5.3.3.2 Centrifugation 95
5.3.3.3 Microfluidics 95
5.4 SUPPLY CHAIN ANALYSIS 95
5.5 VALUE CHAIN ANALYSIS 97
5.6 PRICING ANALYSIS 99
5.6.1 AVERAGE SELLING PRICE TREND OF KEY PRODUCTS,
BY KEY PLAYERS, 2021–2023 100
5.6.2 AVERAGE SELLING PRICE OF KEY PRODUCTS, BY REGION, 2023 101
5.7 ECOSYSTEM ANALYSIS 101
5.7.1 RAW MATERIAL VENDORS IN PHARMACEUTICAL FILTRATION MARKET 102
5.7.2 PRODUCT VENDORS IN PHARMACEUTICAL FILTRATION MARKET 102
5.7.3 END USERS IN PHARMACEUTICAL FILTRATION MARKET 103
5.7.4 REGULATORY BODIES IN PHARMACEUTICAL FILTRATION MARKET 104
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 104
5.9 PATENT ANALYSIS 105
5.9.1 PATENT METHODOLOGY 105
5.9.2 PATENTS FILED, BY DOCUMENT TYPE, 2014–2024 106
5.10 KEY CONFERENCES & EVENTS 107
5.11 REGULATORY LANDSCAPE 108
5.11.1 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS IN DIFFERENT REGIONS/COUNTRIES 108
5.11.2 REGULATORY FRAMEWORK 110
5.12 PORTER’S FIVE FORCES ANALYSIS 111
5.12.1 THREAT OF NEW ENTRANTS 112
5.12.2 THREAT OF SUBSTITUTES 112
5.12.3 BARGAINING POWER OF BUYERS 112
5.12.4 BARGAINING POWER OF SUPPLIERS 112
5.12.5 INTENSITY OF COMPETITIVE RIVALRY 113
5.13 KEY STAKEHOLDERS & BUYING CRITERIA 113
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 113
5.13.2 ROLE OF STAKEHOLDER IN BUYING PROCESS 113
5.13.3 BUYING CRITERIA FOR PHARMACEUTICAL FILTRATION MARKET 114
5.14 CASE STUDY ANALYSIS 115
5.14.1 COST SAVING/OPTIMIZATION 115
5.14.2 SUPPLY CHAIN SIMPLIFICATION 115
5.14.3 COST SAVING AND SYSTEM OPTIMIZATION 115
5.14.4 INTERMITTENT PREMATURE FILTER FOULING SOLVED 115
5.15 INVESTMENT/FUNDING SCENARIO 116
5.16 TRADE DATA ANALYSIS 117
5.17 IMPACT OF AI ON PHARMACEUTICAL FILTRATION MARKET 120
6 PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT 122
6.1 INTRODUCTION 123
6.2 CONSUMABLES 123
6.2.1 FILTERS 128
6.2.1.1 Membrane Filters 132
6.2.1.1.1 Polyethersulfone (PES) 135
6.2.1.1.1.1 Wide use of hydrophilic PES membranes in sterilizing applications to drive growth 135
6.2.1.1.2 Polyvinylidene difluoride (PVDF) 139
6.2.1.1.2.1 Nontoxic nature to increase demand for PVDF filters 139
6.2.1.1.3 Nylon 142
6.2.1.1.3.1 Increased endotoxin adsorption capacity of nylon filters to drive growth 142
6.2.1.1.4 Polytetrafluoroethylene (PTFE) 145
6.2.1.1.4.1 PTFE membrane filters offer retention of ratings as fine as 0.01? 145
6.2.1.1.5 Mixed cellulose ester & cellulose acetate (MCE & CA) 148
6.2.1.1.5.1 Growing analytical and research applications to drive market 148
6.2.1.1.6 Polycarbonate track-etched (PCTE) 152
6.2.1.1.6.1 Wide use in cell biology and analytical testing applications 152
6.2.1.1.7 Other materials 155
6.2.1.2 Depth filters 158
6.2.1.2.1 Diatomaceous earth 161
6.2.1.2.1.1 Increased use in biotechnology industry for cell clarification 161
6.2.1.2.2 Cellulose 165
6.2.1.2.2.1 Cost-effectiveness of cellulose-based depth filters to drive growth 165
6.2.1.2.3 Activated carbon 168
6.2.1.2.3.1 Reliable and cost-effective activated carbon filters supporting pharmaceutical manufacturing operations 168
6.2.1.2.4 Perlite 171
6.2.1.2.4.1 Lower density of perlite provides more purity than diatomaceous earth 171
6.2.1.2.5 Other depth filter media 174
6.2.1.3 Air filters 177
6.2.1.4 Virus filters 180
6.2.1.5 Other filters 183
6.2.2 OTHER CONSUMABLES 187
6.2.2.1 FILTRATION ASSEMBLIES 190
6.2.2.1.1 Microfiltration assemblies 193
6.2.2.1.1.1 Growing demand for high-quality products to support segment growth 193
6.2.2.1.2 Ultrafiltration assemblies 197
6.2.2.1.2.1 Stringent regulatory requirements likely to support segment growth 197
6.2.2.1.3 Nanofiltration assemblies 200
6.2.2.1.3.1 Increasing demand for high-purity biopharmaceuticals to propel segment growth 200
6.2.2.1.4 Other filtration assemblies 204
6.2.3 FILTER HOLDERS 207
6.2.3.1 Filter holders provide structural support to membrane filters 207
?
6.2.4 FILTRATION ACCESSORIES 210
6.2.4.1 Increasing adoption of pharmaceutical filtration products to support growth 210
6.3 SYSTEMS 213
6.3.1 SINGLE-USE SYSTEMS 217
6.3.1.1 Reduced need for product validation and minimized cross-contamination risk to boost adoption 217
6.3.2 REUSABLE SYSTEMS 220
6.3.2.1 Reusable systems widely used for large-scale manufacturing 220
7 PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE 224
7.1 INTRODUCTION 225
7.2 MICROFILTRATION 225
7.2.1 INCREASED ADOPTION OF MICROFILTRATION TO PROPEL MARKET GROWTH 225
7.3 ULTRAFILTRATION 229
7.3.1 ADOPTION OF FINE FILTRATION TECHNIQUES
TO DRIVE GROWTH 229
7.4 NANOFILTRATION 232
7.4.1 RISING DEMAND IN BIOTECHNOLOGY INDUSTRY
TO SUPPORT MARKET GROWTH 232
7.5 OTHER TECHNIQUES 236
8 PHARMACEUTICAL FILTRATION MARKET, BY TYPE 240
8.1 INTRODUCTION 241
8.2 STERILE FILTRATION 241
8.2.1 ADVANTAGES OF STERILE FILTERS OVER NON-STERILE FILTERS TO DRIVE GROWTH 241
8.3 NON-STERILE FILTRATION 245
8.3.1 GROWTH IN PHARMA R&D ACTIVITIES TO PROMOTE MARKET GROWTH 245
9 PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION 248
9.1 INTRODUCTION 249
9.2 FINAL PRODUCT PROCESSING 249
9.2.1 ACTIVE PHARMACEUTICAL INGREDIENT (API) FILTRATION 253
9.2.1.1 Continuous requirement for API filtration 253
9.2.2 PROTEIN PURIFICATION 257
9.2.2.1 Recent advancements in protein therapeutic drugs 257
9.2.3 VACCINE AND ANTIBODY PROCESSING 260
9.2.3.1 Development of vaccines for viral diseases 260
9.2.4 FORMULATION AND FILLING SOLUTIONS 265
9.2.4.1 Demand for aseptic filling and bioburden reduction 265
9.2.5 VIRAL CLEARANCE 268
9.2.5.1 Growing development of therapeutic monoclonal antibodies 268
9.3 RAW MATERIAL FILTRATION 272
9.3.1 MEDIA BUFFER FILTRATION 275
9.3.1.1 Growth in manufacturing of biopharmaceuticals to drive market 275
9.3.2 PREFILTRATION 279
9.3.2.1 High demand due to membrane fouling issues 279
9.3.3 BIOBURDEN TESTING 282
9.3.3.1 Strict quality control of biopharmaceuticals to drive market 282
9.4 CELL SEPARATION 286
9.4.1 GROWTH IN PERSONALIZED MEDICINE TO PROPEL MARKET 286
9.5 WATER PURIFICATION 289
9.5.1 GROWTH IN GERIATRIC POPULATION TO DRIVE MARKET 289
9.6 AIR PURIFICATION 293
9.6.1 INCREASING ADOPTION OF GOOD MANUFACTURING PRACTICES TO DRIVE MARKET 293
10 PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION 297
10.1 INTRODUCTION 298
10.2 MANUFACTURING-SCALE OPERATION 298
10.2.1 GROWTH IN BIOLOGICS AND BIOSIMILAR MANUFACTURING TO DRIVE MARKET 298
10.3 PILOT-SCALE OPERATION 303
10.3.1 INCREASED OUTSOURCING TO DRIVE MARKET GROWTH 303
10.4 R&D-SCALE OPERATION 306
10.4.1 INCREASING INVESTMENTS IN R&D OF BIOLOGICS TO PROPEL GROWTH 306
11 PHARMACEUTICAL FILTRATION MARKET, BY END USER 310
11.1 INTRODUCTION 311
11.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES 311
11.2.1 GROWING BIOLOGICS PRODUCTION TO DRIVE DEMAND 311
11.3 CMOS & CROS 316
11.3.1 INCREASING OUTSOURCING OF R&D SERVICES TO SUPPORT MARKET GROWTH 316
11.4 ACADEMIC & RESEARCH INSTITUTES 319
11.4.1 GROWING PHARMA-ACADEMIA COLLABORATIONS TO DRIVE ADOPTION 319
12 PHARMACEUTICAL FILTRATION MARKET, BY REGION 323
12.1 INTRODUCTION 324
12.2 NORTH AMERICA 324
12.2.1 NORTH AMERICA: MACROECONOMIC ANALYSIS 325
12.2.2 US 333
12.2.2.1 US to dominate North American market during forecast period 333
12.2.3 CANADA 340
12.2.3.1 Growing government support for expanding biologics manufacturing facilities to support market 340
12.3 EUROPE 347
12.3.1 EUROPE: MACROECONOMIC ANALYSIS 347
12.3.2 GERMANY 354
12.3.2.1 Growing pharmaceutical R&D and manufacturing to drive market 354
12.3.3 UK 361
12.3.3.1 Growing awareness of quality of drugs increasing uptake of filtration products in drug discovery labs 361
12.3.4 FRANCE 367
12.3.4.1 Government investment in pharmaceutical industry to drive growth 367
12.3.5 ITALY 374
12.3.5.1 Investment in biotechnology R&D to boost market growth 374
12.3.6 SPAIN 381
12.3.6.1 Expansion of biomanufacturing facilities to support market 381
12.3.7 SWITZERLAND 388
12.3.7.1 Presence of key pharmaceutical and biopharmaceutical companies to support market 388
12.3.8 REST OF EUROPE 395
12.4 ASIA PACIFIC 402
12.4.1 ASIA PACIFIC: MACROECONOMIC ANALYSIS 404
12.4.2 CHINA 412
12.4.2.1 Improving drug development activities to drive market 412
12.4.3 JAPAN 418
12.4.3.1 Stringent regulatory guidelines to create need for advanced filtration products 418
12.4.4 INDIA 425
12.4.4.1 Favorable scenario for foreign direct investment to favor market growth 425
12.4.5 SOUTH KOREA 432
12.4.5.1 Increased export of drugs to support market growth 432
12.4.6 AUSTRALIA 439
12.4.6.1 Increasing demand for innovative filtration solutions to propel market 439
12.4.7 REST OF ASIA PACIFIC 445
12.5 LATIN AMERICA 452
12.5.1 LATIN AMERICA: MACROECONOMIC ANALYSIS 453
12.5.2 BRAZIL 460
12.5.2.1 Increased government investments in pharmaceutical R&D to drive market 460
12.5.3 MEXICO 466
12.5.3.1 Rising demand for chronic disease treatment to support market growth 466
12.5.4 REST OF LATIN AMERICA 472
12.6 MIDDLE EAST 478
12.6.1 MIDDLE EAST: MACROECONOMIC ANALYSIS 479
12.6.2 GCC COUNTRIES 486
12.6.3 SAUDI ARABIA 493
12.6.3.1 Growing healthcare expenditure to boost market growth 493
12.6.4 UAE 500
12.6.4.1 Adoption of more efficient and precise filtration processes to aid market growth 500
12.6.5 REST OF GCC COUNTRIES 506
12.6.6 REST OF MIDDLE EAST 512
12.7 AFRICA 519
12.7.1 AFRICA: MACROECONOMIC ANALYSIS 519
13 COMPETITIVE LANDSCAPE 527
13.1 INTRODUCTION 527
13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022?2024 527
13.3 REVENUE SHARE ANALYSIS, 2019–2023 529
13.4 MARKET SHARE ANALYSIS, 2023 529
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 531
13.5.1 STARS 532
13.5.2 EMERGING LEADERS 532
13.5.3 PERVASIVE PLAYERS 532
13.5.4 PARTICIPANTS 532
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 534
13.5.5.1 Company footprint 534
13.5.5.2 Product footprint 535
13.5.5.3 Technique footprint 536
13.5.5.4 Application footprint 537
13.5.5.5 Region footprint 539
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 540
13.6.1 PROGRESSIVE COMPANIES 540
13.6.2 RESPONSIVE COMPANIES 540
13.6.3 DYNAMIC COMPANIES 540
13.6.4 STARTING BLOCKS 540
13.7 COMPETITIVE BENCHMARKING OF STARTUPS/SMES, 2023 542
13.8 VALUATION AND FINANCIAL METRICS OF PHARMACEUTICAL FILTRATION VENDORS 544
13.9 BRAND/PRODUCT COMPARATIVE ANALYSIS 545
13.9.1 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY PRODUCT 545
13.10 COMPETITIVE SCENARIO 546
13.10.1 PRODUCT LAUNCHES 546
13.10.2 DEALS 547
13.10.3 EXPANSIONS 548
?
14 COMPANY PROFILES 549
14.1 KEY PLAYERS 549
14.1.1 DANAHER CORPORATION 549
14.1.1.1 Business overview 549
14.1.1.2 Products offered 550
14.1.1.3 Recent developments 556
14.1.1.3.1 Product launches 556
14.1.1.3.2 Deals 557
14.1.1.3.3 Expansions 557
14.1.1.4 MnM view 558
14.1.1.4.1 Key strengths 558
14.1.1.4.2 Strategic choices 558
14.1.1.4.3 Weaknesses and competitive threats 558
14.1.2 MERCK KGAA 559
14.1.2.1 Business overview 559
14.1.2.2 Products offered 560
14.1.2.3 Recent developments 565
14.1.2.3.1 Expansions 565
14.1.2.3.2 Other developments 566
14.1.2.4 MnM view 566
14.1.2.4.1 Key strengths 566
14.1.2.4.2 Strategic choices 566
14.1.2.4.3 Weaknesses and competitive threats 567
14.1.3 SARTORIUS AG 568
14.1.3.1 Business overview 568
14.1.3.2 Products offered 569
14.1.3.3 Recent developments 572
14.1.3.3.1 Product launches 572
14.1.3.3.2 Deals 572
14.1.3.3.3 Expansions 573
14.1.3.4 MnM view 573
14.1.3.4.1 Key strengths 573
14.1.3.4.2 Strategic choices 573
14.1.3.4.3 Weaknesses and competitive threats 574
14.1.4 3M COMPANY 575
14.1.4.1 Business overview 575
14.1.4.2 Products offered 576
14.1.4.3 Recent developments 579
14.1.4.3.1 Product launches 579
14.1.4.3.2 Deals 579
14.1.4.3.3 Other developments 580
14.1.4.4 MnM view 580
14.1.4.4.1 Key strengths 580
14.1.4.4.2 Strategic choices 580
14.1.4.4.3 Weaknesses and competitive threats 580
14.1.5 REPLIGEN CORPORATION 581
14.1.5.1 Business overview 581
14.1.5.2 Products offered 582
14.1.5.3 Recent developments 584
14.1.5.3.1 Product launches 584
14.1.5.3.2 Deals 584
14.1.5.4 MnM view 584
14.1.5.4.1 Key strengths 584
14.1.5.4.2 Strategic choices 585
14.1.5.4.3 Weaknesses and competitive threats 585
14.1.6 PARKER HANNIFIN CORPORATION 586
14.1.6.1 Business overview 586
14.1.6.2 Products offered 587
14.1.7 EATON CORPORATION PLC 589
14.1.7.1 Business overview 589
14.1.7.2 Products offered 591
14.1.7.3 Recent developments 592
14.1.7.3.1 Product launches 592
14.1.8 THERMO FISHER SCIENTIFIC, INC. 593
14.1.8.1 Business overview 593
14.1.8.2 Products offered 594
14.1.8.3 Recent developments 597
14.1.8.3.1 Expansions 597
14.1.9 DONALDSON COMPANY, INC. 599
14.1.9.1 Business overview 599
14.1.9.2 Products offered 600
14.1.9.3 Recent developments 601
14.1.9.3.1 Deals 601
14.1.9.3.2 Expansions 602
14.1.10 PORVAIR PLC 603
14.1.10.1 Business overview 603
14.1.10.2 Products offered 604
14.1.10.3 Recent developments 606
14.1.10.3.1 Product launches 606
14.1.11 ALFA LAVAL CORPORATE AB 607
14.1.11.1 Business overview 607
14.1.11.2 Products offered 608
14.1.11.3 Recent developments 609
14.1.11.3.1 Product launches 609
14.1.12 CORNING INCORPORATED 610
14.1.12.1 Business overview 610
14.1.12.2 Products offered 611
14.1.13 MANN+HUMMEL 614
14.1.13.1 Business overview 614
14.1.13.2 Products offered 615
14.1.13.3 Recent developments 616
14.1.13.3.1 Deals 616
14.1.14 SAINT-GOBAIN 617
14.1.14.1 Business overview 617
14.1.14.2 Products offered 618
14.1.14.3 Recent developments 618
14.1.14.3.1 Product launches 618
14.1.14.3.2 Expansions 619
14.1.15 STERIS PLC 620
14.1.15.1 Business overview 620
14.1.15.2 Products offered 621
14.2 OTHER PLAYERS 622
14.2.1 MEISSNER FILTRATION PRODUCTS, INC. 622
14.2.2 AMAZON FILTERS LTD. 624
14.2.3 GRAVER TECHNOLOGIES, LLC. 626
14.2.4 MMS AG 628
14.2.5 ERTELALSOP 629
14.2.6 KASAG SWISS AG 630
14.2.7 FREUDENBERG FILTRATION TECHNOLOGIES SE & CO. KG 631
14.2.8 COLE-PARMER INSTRUMENT COMPANY, LLC 632
14.2.9 FILTROX AG 633
14.2.10 MEMBRANE SOLUTIONS 634
15 APPENDIX 635
15.1 DISCUSSION GUIDE 635
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS? SUBSCRIPTION PORTAL 641
15.3 CUSTOMIZATION OPTIONS 643
15.4 RELATED REPORTS 644
15.5 AUTHOR DETAILS 645



List of Figures

FIGURE 1 MARKETS COVERED AND REGIONAL SCOPE 56
FIGURE 2 RESEARCH DESIGN 59
FIGURE 3 PHARMACEUTICAL FILTRATION MARKET: BREAKDOWN OF PRIMARIES 62
FIGURE 4 PHARMACEUTICAL FILTRATION MARKET SIZE ESTIMATION
(SUPPLY-SIDE ANALYSIS), 2023 64
FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023 65
FIGURE 6 ILLUSTRATIVE EXAMPLE OF SARTORIUS AG: REVENUE ANALYSIS (2023) 66
FIGURE 7 MARKET SIZE VALIDATION FROM PRIMARY SOURCES 67
FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 68
FIGURE 9 PHARMACEUTICAL FILTRATION MARKET: CAGR PROJECTIONS 69
FIGURE 10 DATA TRIANGULATION METHODOLOGY 71
FIGURE 11 PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2024 VS. 2029 74
FIGURE 12 PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2024 VS. 2029 75
FIGURE 13 PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2024 VS. 2029 75
FIGURE 14 PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2024 VS. 2029 76
FIGURE 15 GEOGRAPHICAL SNAPSHOT OF PHARMACEUTICAL FILTRATION MARKET 77
FIGURE 16 GROWING DEMAND FOR DRUG DISCOVERY & DEVELOPMENT TO DRIVE MARKET 78
FIGURE 17 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN PHARMACEUTICAL
FILTRATION MARKET IN 2023 79
FIGURE 18 CONSUMABLES SEGMENT ACCOUNTED FOR LARGER MARKET SHARE IN 2023 80
FIGURE 19 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT ACCOUNTED FOR LARGEST SHARE 80
FIGURE 20 ASIA PACIFIC COUNTRIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD 81
FIGURE 21 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN PHARMACEUTICAL FILTRATION MARKET 82
FIGURE 22 GLOBAL PHARMACEUTICAL R&D SPENDING, 2021–2030 85
FIGURE 23 PHARMACEUTICAL FILTRATION MARKET: SUPPLY CHAIN ANALYSIS 96
FIGURE 24 VALUE CHAIN ANALYSIS OF PHARMACEUTICAL FILTRATION MARKET 98
FIGURE 25 AVERAGE SELLING PRICE TREND OF KEY PRODUCTS, 2021–2023 100
FIGURE 26 AVERAGE SELLING PRICE OF KEY PRODUCTS, BY REGION, 2023 101
FIGURE 27 PHARMACEUTICAL FILTRATION MARKET: ECOSYSTEM ANALYSIS 102
FIGURE 28 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 105
FIGURE 29 PATENT ANALYSIS, PHARMACEUTICAL FILTRATION MARKET, 2014–2024 106
FIGURE 30 PHARMACEUTICAL FILTRATION MARKET: PORTERS FIVE ANALYSIS 111
FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF PHARMACEUTICAL FILTRATION PRODUCTS 113
FIGURE 32 KEY BUYING CRITERIA FOR END USERS 114
FIGURE 33 NUMBER OF ANTIBODY THERAPEUTICS GRANTED FIRST APPROVAL IN US
OR EU, 2012 TO 2023 261
FIGURE 34 NUMBER OF FDA-APPROVED DRUGS, 2015–2023 312
FIGURE 35 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET SNAPSHOT 326
FIGURE 36 NIH FUNDING IN LAST 10 YEARS (2014–2024) 334
FIGURE 37 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET SNAPSHOT 403
FIGURE 38 PHARMACEUTICAL FILTRATION MARKET: REVENUE ANALYSIS OF KEY PLAYERS, 2019–2023 529
FIGURE 39 PHARMACEUTICAL FILTRATION MARKET: MARKET SHARE ANALYSIS OF KEY PLAYERS, 2023 530
FIGURE 40 PHARMACEUTICAL FILTRATION MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 533
FIGURE 41 PHARMACEUTICAL FILTRATION MARKET: COMPANY FOOTPRINT 534
FIGURE 42 PHARMACEUTICAL FILTRATION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 541
FIGURE 43 EV/EBITDA OF KEY VENDORS, 2024 544
FIGURE 44 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 544
FIGURE 45 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY PRODUCT 545
FIGURE 46 DANAHER CORPORATION: COMPANY SNAPSHOT (2023) 550
FIGURE 47 MERCK KGAA: COMPANY SNAPSHOT (2023) 560
FIGURE 48 SARTORIUS AG: COMPANY SNAPSHOT (2023) 569
FIGURE 49 3M COMPANY: COMPANY SNAPSHOT (2023) 576
FIGURE 50 REPLIGEN CORPORATION: COMPANY SNAPSHOT (2023) 582
FIGURE 51 PARKER HANNIFIN CORPORATION: COMPANY SNAPSHOT (2023) 587
FIGURE 52 EATON CORPORATION PLC: COMPANY SNAPSHOT (2023) 590
FIGURE 53 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2023) 594
FIGURE 54 DONALDSON COMPANY, INC.: COMPANY SNAPSHOT (2023) 600
FIGURE 55 PORVAIR PLC: COMPANY SNAPSHOT (2023) 604
FIGURE 56 ALFA LAVAL CORPORATE AB: COMPANY SNAPSHOT (2023) 608
FIGURE 57 CORNING INCORPORATED: COMPANY SNAPSHOT (2023) 611
FIGURE 58 MANN+HUMMEL: COMPANY SNAPSHOT (2023) 615
FIGURE 59 SAINT-GOBAIN: COMPANY SNAPSHOT (2023) 617
FIGURE 60 STERIS PLC: COMPANY SNAPSHOT (2023) 621

List of Tables

TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS 70
TABLE 2 PHARMACEUTICAL FILTRATION MARKET: IMPACT ANALYSIS 83
TABLE 3 LIST OF TOP BIOLOGICAL LICENSE APPLICATION APPROVALS, 2023 84
TABLE 4 PHARMACEUTICAL R&D SPENDING, BY COMPANY, 2023 (USD BILLION) 86
TABLE 5 AVERAGE SELLING PRICE TREND OF KEY PRODUCTS, BY KEY PLAYERS 2021–2023 100
TABLE 6 AVERAGE SELLING PRICE OF KEY PRODUCTS, BY REGION, 2023
(PRICE RANGE IN USD) 101
TABLE 7 PHARMACEUTICAL FILTRATION MARKET: ROLE OF RAW MATERIAL VENDORS 102
TABLE 8 PHARMACEUTICAL FILTRATION MARKET: ROLE OF PRODUCT VENDORS 103
TABLE 9 PHARMACEUTICAL FILTRATION MARKET: ROLE OF END USERS 103
TABLE 10 PHARMACEUTICAL FILTRATION MARKET: ROLE OF REGULATORY BODIES 104
TABLE 11 PATENTS FILED, 2014–2024 106
TABLE 12 PHARMACEUTICAL FILTRATION MARKET: KEY CONFERENCES & EVENTS 2025–2026 107
TABLE 13 PHARMACEUTICAL FILTRATION MARKET: PORTER’S FIVE FORCES ANALYSIS 111
TABLE 14 BUYING CRITERIA FOR PHARMACEUTICAL FILTRATION PRODUCTS, BY END USER 114
TABLE 15 IMPORT VALUE FOR HS CODE 8421 (TOP 20 COUNTRIES) 2019–2023 (USD THOUSAND) 117
TABLE 16 EXPORT VALUE FOR HS CODE 8421 (TOP 20 COUNTRIES) 2019–2023 (USD THOUSAND) 118
TABLE 17 IMPORT VOLUME FOR HS CODE 8421 FOR TOP 20 COUNTRIES 2019–2023 (TONS) 119
TABLE 18 EXPORT VOLUME FOR HS CODE 8421 FOR TOP 20 COUNTRIES 2019–2023 (TONS) 120
TABLE 19 GLOBAL PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT 2022–2029 (USD MILLION) 123
TABLE 20 GLOBAL PHARMACEUTICAL CONSUMABLES MARKET, BY REGION 2022–2029 (USD MILLION) 124
TABLE 21 NORTH AMERICA: PHARMACEUTICAL CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 124
TABLE 22 EUROPE: PHARMACEUTICAL CONSUMABLES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 125
TABLE 23 ASIA PACIFIC: PHARMACEUTICAL CONSUMABLES MARKET, BY COUNTRY/
REGION, 2022–2029 (USD MILLION) 125
TABLE 24 LATIN AMERICA: PHARMACEUTICAL CONSUMABLES MARKET, BY COUNTRY/ REGION, 2022–2029 (USD MILLION) 126
TABLE 25 MIDDLE EAST: PHARMACEUTICAL CONSUMABLES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 126
TABLE 26 GCC COUNTRIES: PHARMACEUTICAL CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 126
TABLE 27 GLOBAL PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 127
TABLE 28 GLOBAL PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 127
TABLE 29 PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE 2022–2029 (USD MILLION) 128
TABLE 30 GLOBAL PHARMACEUTICAL FILTERS MARKET, BY REGION 2022–2029 (USD MILLION) 128
TABLE 31 NORTH AMERICA: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 129
TABLE 32 EUROPE: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 129
TABLE 33 ASIA PACIFIC: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 130
TABLE 34 LATIN AMERICA: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 130
TABLE 35 MIDDLE EAST: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 130
TABLE 36 GCC COUNTRIES: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 131
TABLE 37 GLOBAL PHARMACEUTICAL FILTERS MARKET, BY TYPE 2022–2029 (USD MILLION) 131
TABLE 38 GLOBAL PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY REGION 2022–2029 (USD MILLION) 132
TABLE 39 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 133
TABLE 40 EUROPE: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 133
TABLE 41 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTERS MARKET BY COUNTRY/REGION, 2022–2029 (USD MILLION) 134
TABLE 42 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTERS MARKET BY COUNTRY/REGION, 2022–2029 (USD MILLION) 134
TABLE 43 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTERS MARKET BY COUNTRY/REGION, 2022–2029 (USD MILLION) 134
TABLE 44 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 135
TABLE 45 MEMBRANE FILTERS MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 135
TABLE 46 GLOBAL PES MEMBRANE FILTERS MARKET, BY REGION 2022–2029 (USD MILLION) 136
TABLE 47 NORTH AMERICA: PES MEMBRANE FILTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 136
TABLE 48 EUROPE: PES MEMBRANE FILTERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 137
TABLE 49 ASIA PACIFIC: PES MEMBRANE FILTERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 137
TABLE 50 LATIN AMERICA: PES MEMBRANE FILTERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 138
TABLE 51 MIDDLE EAST: PES MEMBRANE FILTERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 138
TABLE 52 GCC COUNTRIES: PES MEMBRANE FILTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 138
TABLE 53 GLOBAL PVDF MEMBRANE FILTERS MARKET, BY REGION 2022–2029 (USD MILLION) 139
TABLE 54 NORTH AMERICA: PVDF MEMBRANE FILTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 140
TABLE 55 EUROPE: PVDF MEMBRANE FILTERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 140
TABLE 56 ASIA PACIFIC: PVDF MEMBRANE FILTERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 141
TABLE 57 LATIN AMERICA: PVDF MEMBRANE FILTERS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 141
TABLE 58 MIDDLE EAST: PVDF MEMBRANE FILTERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 141
TABLE 59 GCC COUNTRIES: PVDF MEMBRANE FILTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 142
TABLE 60 GLOBAL NYLON MEMBRANE FILTERS MARKET, BY REGION 2022–2029 (USD MILLION) 142
TABLE 61 NORTH AMERICA: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 143
TABLE 62 EUROPE: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 143
TABLE 63 ASIA PACIFIC: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 144
TABLE 64 LATIN AMERICA: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 144
TABLE 65 MIDDLE EAST: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 144
TABLE 66 GCC COUNTRIES: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 145
TABLE 67 GLOBAL PTFE MEMBRANE FILTERS MARKET, BY REGION 2022–2029 (USD MILLION) 145
TABLE 68 NORTH AMERICA: PTFE MEMBRANE FILTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 146
TABLE 69 EUROPE: PTFE MEMBRANE FILTERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 146
TABLE 70 ASIA PACIFIC: PTFE MEMBRANE FILTERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 147
TABLE 71 LATIN AMERICA: PTFE MEMBRANE FILTERS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 147
TABLE 72 MIDDLE EAST: PTFE MEMBRANE FILTERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 147
TABLE 73 GCC COUNTRIES: PTFE MEMBRANE FILTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 148
TABLE 74 GLOBAL MCE & CA MEMBRANE FILTERS MARKET, BY REGION 2022–2029 (USD MILLION) 149
TABLE 75 NORTH AMERICA: MCE & CA MEMBRANE FILTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 149
TABLE 76 EUROPE: MCE & CA MEMBRANE FILTERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 150
TABLE 77 ASIA PACIFIC: MCE & CA MEMBRANE FILTERS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 150
TABLE 78 LATIN AMERICA: MCE & CA MEMBRANE FILTERS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 151
TABLE 79 MIDDLE EAST: MCE & CA MEMBRANE FILTERS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 151
TABLE 80 GCC COUNTRIES: MCE & CA MEMBRANE FILTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 151
TABLE 81 GLOBAL PCTE MEMBRANE FILTERS MARKET, BY REGION 2022–2029 (USD MILLION) 152
TABLE 82 NORTH AMERICA: PCTE MEMBRANE FILTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 152
TABLE 83 EUROPE: PCTE MEMBRANE FILTERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 153
TABLE 84 ASIA PACIFIC: PCTE MEMBRANE FILTERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 153
TABLE 85 LATIN AMERICA: PCTE MEMBRANE FILTERS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 154
TABLE 86 MIDDLE EAST: PCTE MEMBRANE FILTERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 154
TABLE 87 GCC COUNTRIES: PCTE MEMBRANE FILTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 154
TABLE 88 GLOBAL OTHER MATERIAL MEMBRANE FILTERS MARKET, BY REGION 2022–2029 (USD MILLION) 155
TABLE 89 NORTH AMERICA: OTHER MATERIAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 155
TABLE 90 EUROPE: OTHER MATERIAL MEMBRANE FILTERS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 156
TABLE 91 ASIA PACIFIC: OTHER MATERIAL MEMBRANE FILTERS MARKET, BY COUNTRY/ REGION, 2022–2029 (USD MILLION) 156
TABLE 92 LATIN AMERICA: OTHER MATERIAL MEMBRANE FILTERS MARKET, BY COUNTRY/ REGION, 2022–2029 (USD MILLION) 157
TABLE 93 MIDDLE EAST: OTHER MATERIAL MEMBRANE FILTERS MARKET BY COUNTRY/REGION, 2022–2029 (USD MILLION) 157
TABLE 94 GCC COUNTRIES: OTHER MATERIAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 157
TABLE 95 GLOBAL DEPTH FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 158
TABLE 96 NORTH AMERICA: DEPTH FILTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 159
TABLE 97 EUROPE: DEPTH FILTERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 159
TABLE 98 ASIA PACIFIC: DEPTH FILTERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 160
TABLE 99 LATIN AMERICA: DEPTH FILTERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 160
TABLE 100 MIDDLE EAST: DEPTH FILTERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 160
TABLE 101 GCC COUNTRIES: DEPTH FILTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 161
TABLE 102 DEPTH FILTERS MARKET, BY TYPE OF MEDIA, 2022–2029 (USD MILLION) 161
TABLE 103 GLOBAL DIATOMACEOUS EARTH FILTERS MARKET, BY REGION 2022–2029 (USD MILLION) 162
TABLE 104 NORTH AMERICA: DIATOMACEOUS EARTH FILTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 162
TABLE 105 EUROPE: DIATOMACEOUS EARTH FILTERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 163
TABLE 106 ASIA PACIFIC: DIATOMACEOUS EARTH FILTERS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 163
TABLE 107 LATIN AMERICA: DIATOMACEOUS EARTH FILTERS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 164
TABLE 108 MIDDLE EAST: DIATOMACEOUS EARTH FILTERS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 164
TABLE 109 GCC COUNTRIES: DIATOMACEOUS EARTH FILTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 164
TABLE 110 GLOBAL CELLULOSE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 165
TABLE 111 NORTH AMERICA: CELLULOSE FILTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 165
TABLE 112 EUROPE: CELLULOSE FILTERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 166
TABLE 113 ASIA PACIFIC: CELLULOSE FILTERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 166
TABLE 114 LATIN AMERICA: CELLULOSE FILTERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 167
TABLE 115 MIDDLE EAST: CELLULOSE FILTERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 167
TABLE 116 GCC COUNTRIES: CELLULOSE FILTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 167
TABLE 117 GLOBAL ACTIVATED CARBON FILTERS MARKET, BY REGION 2022–2029 (USD MILLION) 168
TABLE 118 NORTH AMERICA: ACTIVATED CARBON FILTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 168
TABLE 119 EUROPE: ACTIVATED CARBON FILTERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 169
TABLE 120 ASIA PACIFIC: ACTIVATED CARBON FILTERS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 169
TABLE 121 LATIN AMERICA: ACTIVATED CARBON FILTERS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 170
TABLE 122 MIDDLE EAST: ACTIVATED CARBON FILTERS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 170
TABLE 123 GCC COUNTRIES: ACTIVATED CARBON FILTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 170
TABLE 124 GLOBAL PERLITE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 171
TABLE 125 NORTH AMERICA: PERLITE FILTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 171
TABLE 126 EUROPE: PERLITE FILTERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 172
TABLE 127 ASIA PACIFIC: PERLITE FILTERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 172
TABLE 128 LATIN AMERICA: PERLITE FILTERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 173
TABLE 129 MIDDLE EAST: PERLITE FILTERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 173
TABLE 130 GCC COUNTRIES: PERLITE FILTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 173
TABLE 131 GLOBAL OTHER DEPTH FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 174
TABLE 132 NORTH AMERICA: OTHER DEPTH FILTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 174
TABLE 133 EUROPE: OTHER DEPTH FILTERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 175
TABLE 134 ASIA PACIFIC: OTHER DEPTH FILTERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 175
TABLE 135 LATIN AMERICA: OTHER DEPTH FILTERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 176
TABLE 136 MIDDLE EAST: OTHER DEPTH FILTERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 176
TABLE 137 GCC COUNTRIES: OTHER DEPTH FILTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 176
TABLE 138 GLOBAL AIR FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 177
TABLE 139 NORTH AMERICA: AIR FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 178
TABLE 140 EUROPE: AIR FILTERS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 178
TABLE 141 ASIA PACIFIC: AIR FILTERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 179
TABLE 142 LATIN AMERICA: AIR FILTERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 179
TABLE 143 MIDDLE EAST: AIR FILTERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 179
TABLE 144 GCC COUNTRIES: AIR FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 180
TABLE 145 GLOBAL VIRUS FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 180
TABLE 146 NORTH AMERICA: VIRUS FILTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 181
TABLE 147 EUROPE: VIRUS FILTERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 181
TABLE 148 ASIA PACIFIC: VIRUS FILTERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 182
TABLE 149 LATIN AMERICA: VIRUS FILTERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 182
TABLE 150 MIDDLE EAST: VIRUS FILTERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 183
TABLE 151 GCC COUNTRIES: VIRUS FILTERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 183
TABLE 152 GLOBAL OTHER PHARMACEUTICAL FILTERS MARKET, BY REGION 2022–2029 (USD MILLION) 184
TABLE 153 NORTH AMERICA: OTHER PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 184
TABLE 154 EUROPE: OTHER PHARMACEUTICAL FILTERS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 185
TABLE 155 ASIA PACIFIC: OTHER PHARMACEUTICAL FILTERS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 185
TABLE 156 LATIN AMERICA: OTHER PHARMACEUTICAL FILTERS MARKET BY COUNTRY/REGION, 2022–2029 (USD MILLION) 186
TABLE 157 MIDDLE EAST: OTHER PHARMACEUTICAL FILTERS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 186
TABLE 158 GCC COUNTRIES: OTHER PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 186
TABLE 159 GLOBAL OTHER CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION) 187
TABLE 160 NORTH AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY 2022–2029 (USD MILLION) 187
TABLE 161 EUROPE: OTHER CONSUMABLES MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 188
TABLE 162 ASIA PACIFIC: OTHER CONSUMABLES MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 188
TABLE 163 LATIN AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 189
TABLE 164 MIDDLE EAST: OTHER CONSUMABLES MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 189
TABLE 165 GCC COUNTRIES: OTHER CONSUMABLES MARKET, BY COUNTRY 2022–2029 (USD MILLION) 189
TABLE 166 OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE 2022–2029 (USD MILLION) 190
TABLE 167 GLOBAL FILTRATION ASSEMBLIES MARKET, BY REGION 2022–2029 (USD MILLION) 190
TABLE 168 NORTH AMERICA: FILTRATION ASSEMBLIES MARKET, BY COUNTRY 2022–2029 (USD MILLION) 191
TABLE 169 EUROPE: FILTRATION ASSEMBLIES MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 191
TABLE 170 ASIA PACIFIC: FILTRATION ASSEMBLIES MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 192
TABLE 171 LATIN AMERICA: FILTRATION ASSEMBLIES MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 192
TABLE 172 MIDDLE EAST: FILTRATION ASSEMBLIES MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 192
TABLE 173 GCC COUNTRIES: FILTRATION ASSEMBLIES MARKET, BY COUNTRY 2022–2029 (USD MILLION) 193
TABLE 174 PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE 2022–2029 (USD MILLION) 193
TABLE 175 GLOBAL MICROFILTRATION ASSEMBLIES MARKET, BY REGION 2022–2029 (USD MILLION) 194
TABLE 176 NORTH AMERICA: MICROFILTRATION ASSEMBLIES MARKET, BY COUNTRY 2022–2029 (USD MILLION) 194
TABLE 177 EUROPE: MICROFILTRATION ASSEMBLIES MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 195
TABLE 178 ASIA PACIFIC: MICROFILTRATION ASSEMBLIES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 195
TABLE 179 LATIN AMERICA: MICROFILTRATION ASSEMBLIES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 196
TABLE 180 MIDDLE EAST: MICROFILTRATION ASSEMBLIES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 196
TABLE 181 GCC COUNTRIES: MICROFILTRATION ASSEMBLIES MARKET, BY COUNTRY 2022–2029 (USD MILLION) 196
TABLE 182 GLOBAL ULTRAFILTRATION ASSEMBLIES MARKET, BY REGION 2022–2029 (USD MILLION) 197
TABLE 183 NORTH AMERICA: ULTRAFILTRATION ASSEMBLIES MARKET, BY COUNTRY 2022–2029 (USD MILLION) 198
TABLE 184 EUROPE: ULTRAFILTRATION ASSEMBLIES MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 198
TABLE 185 ASIA PACIFIC: ULTRAFILTRATION ASSEMBLIES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 199
TABLE 186 LATIN AMERICA: ULTRAFILTRATION ASSEMBLIES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 199
TABLE 187 MIDDLE EAST: ULTRAFILTRATION ASSEMBLIES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 199
TABLE 188 GCC COUNTRIES: ULTRAFILTRATION ASSEMBLIES MARKET, BY COUNTRY 2022–2029 (USD MILLION) 200
TABLE 189 GLOBAL NANOFILTRATION ASSEMBLIES MARKET, BY REGION 2022–2029 (USD MILLION) 201
TABLE 190 NORTH AMERICA: NANOFILTRATION ASSEMBLIES MARKET, BY COUNTRY 2022–2029 (USD MILLION) 201
TABLE 191 EUROPE: NANOFILTRATION ASSEMBLIES MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 202
TABLE 192 ASIA PACIFIC: NANOFILTRATION ASSEMBLIES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 202
TABLE 193 LATIN AMERICA: NANOFILTRATION ASSEMBLIES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 203
TABLE 194 MIDDLE EAST: NANOFILTRATION ASSEMBLIES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 203
TABLE 195 GCC COUNTRIES: NANOFILTRATION ASSEMBLIES MARKET, BY COUNTRY 2022–2029 (USD MILLION) 203
TABLE 196 GLOBAL OTHER FILTRATION ASSEMBLIES MARKET, BY REGION 2022–2029 (USD MILLION) 204
TABLE 197 NORTH AMERICA: OTHER FILTRATION ASSEMBLIES MARKET, BY COUNTRY 2022–2029 (USD MILLION) 204
TABLE 198 EUROPE: OTHER FILTRATION ASSEMBLIES MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 205
TABLE 199 ASIA PACIFIC: OTHER FILTRATION ASSEMBLIES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 205
TABLE 200 LATIN AMERICA: OTHER FILTRATION ASSEMBLIES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 206
TABLE 201 MIDDLE EAST: OTHER FILTRATION ASSEMBLIES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 206
TABLE 202 GCC COUNTRIES: OTHER FILTRATION ASSEMBLIES MARKET, BY COUNTRY 2022–2029 (USD MILLION) 206
TABLE 203 GLOBAL FILTER HOLDERS MARKET, BY REGION, 2022–2029 (USD MILLION) 207
TABLE 204 NORTH AMERICA: FILTER HOLDERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 207
TABLE 205 EUROPE: FILTER HOLDERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 208
TABLE 206 ASIA PACIFIC: FILTER HOLDERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 208
TABLE 207 LATIN AMERICA: FILTER HOLDERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 209
TABLE 208 MIDDLE EAST: FILTER HOLDERS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 209
TABLE 209 GCC COUNTRIES: FILTER HOLDERS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 209
TABLE 210 GLOBAL FILTER ACCESSORIES MARKET, BY REGION, 2022–2029 (USD MILLION) 210
TABLE 211 NORTH AMERICA: FILTER ACCESSORIES MARKET, BY COUNTRY 2022–2029 (USD MILLION) 210
TABLE 212 EUROPE: FILTER ACCESSORIES MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 211
TABLE 213 ASIA PACIFIC: FILTER ACCESSORIES MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 211
TABLE 214 LATIN AMERICA: FILTER ACCESSORIES MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 212
TABLE 215 MIDDLE EAST: FILTER ACCESSORIES MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 212
TABLE 216 GCC COUNTRIES: FILTER ACCESSORIES MARKET, BY COUNTRY 2022–2029 (USD MILLION) 212
TABLE 217 GLOBAL FILTRATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 213
TABLE 218 NORTH AMERICA: FILTRATION SYSTEMS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 213
TABLE 219 EUROPE: FILTRATION SYSTEMS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 214
TABLE 220 ASIA PACIFIC: FILTRATION SYSTEMS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 214
TABLE 221 LATIN AMERICA: FILTRATION SYSTEMS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 215
TABLE 222 MIDDLE EAST: FILTRATION SYSTEMS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 215
TABLE 223 GCC COUNTRIES: FILTRATION SYSTEMS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 215
TABLE 224 GLOBAL PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 216
TABLE 225 GLOBAL PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TECHNIQUE 2022–2029 (USD MILLION) 216
TABLE 226 GLOBAL FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 216
TABLE 227 GLOBAL SINGLE-USE FILTRATION SYSTEMS MARKET, BY REGION 2022–2029 (USD MILLION) 217
TABLE 228 NORTH AMERICA: SINGLE-USE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 218
TABLE 229 EUROPE: SINGLE-USE FILTRATION SYSTEMS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 218
TABLE 230 ASIA PACIFIC: SINGLE-USE FILTRATION SYSTEMS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 219
TABLE 231 LATIN AMERICA: SINGLE-USE FILTRATION SYSTEMS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 219
TABLE 232 MIDDLE EAST: SINGLE-USE FILTRATION SYSTEMS MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 219
TABLE 233 GCC COUNTRIES: SINGLE-USE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 220
TABLE 234 GLOBAL REUSABLE SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 220
TABLE 235 NORTH AMERICA: REUSABLE SYSTEMS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 221
TABLE 236 EUROPE: REUSABLE SYSTEMS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 221
TABLE 237 ASIA PACIFIC: REUSABLE SYSTEMS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 222
TABLE 238 LATIN AMERICA: REUSABLE SYSTEMS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 222
TABLE 239 MIDDLE EAST: REUSABLE SYSTEMS MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 223
TABLE 240 GCC COUNTRIES: REUSABLE SYSTEMS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 223
TABLE 241 GLOBAL PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE 2022–2029 (USD MILLION) 225
TABLE 242 GLOBAL MICROFILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION) 226
TABLE 243 NORTH AMERICA: MICROFILTRATION MARKET, BY COUNTRY 2022–2029 (USD MILLION) 226
TABLE 244 EUROPE: MICROFILTRATION MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 227
TABLE 245 ASIA PACIFIC: MICROFILTRATION MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 227
TABLE 246 LATIN AMERICA: MICROFILTRATION MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 228
TABLE 247 MIDDLE EAST: MICROFILTRATION MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 228
TABLE 248 GCC COUNTRIES: MICROFILTRATION MARKET, BY COUNTRY 2022–2029 (USD MILLION) 228
TABLE 249 GLOBAL ULTRAFILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION) 229
TABLE 250 NORTH AMERICA: ULTRAFILTRATION MARKET, BY COUNTRY 2022–2029 (USD MILLION) 230
TABLE 251 EUROPE: ULTRAFILTRATION MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 230
TABLE 252 ASIA PACIFIC: ULTRAFILTRATION MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 231
TABLE 253 LATIN AMERICA: ULTRAFILTRATION MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 231
TABLE 254 MIDDLE EAST: ULTRAFILTRATION MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 231
TABLE 255 GCC COUNTRIES: ULTRAFILTRATION MARKET, BY COUNTRY 2022–2029 (USD MILLION) 232
TABLE 256 GLOBAL NANOFILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION) 233
TABLE 257 NORTH AMERICA: NANOFILTRATION MARKET, BY COUNTRY 2022–2029 (USD MILLION) 233
TABLE 258 EUROPE: NANOFILTRATION MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 234
TABLE 259 ASIA PACIFIC: NANOFILTRATION MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 234
TABLE 260 LATIN AMERICA: NANOFILTRATION MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 235
TABLE 261 MIDDLE EAST: NANOFILTRATION MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 235
TABLE 262 GCC COUNTRIES: NANOFILTRATION MARKET, BY COUNTRY 2022–2029 (USD MILLION) 235
TABLE 263 GLOBAL OTHER FILTRATION TECHNIQUES MARKET, BY REGION 2022–2029 (USD MILLION) 236
TABLE 264 NORTH AMERICA: OTHER FILTRATION TECHNIQUES MARKET, BY COUNTRY 2022–2029 (USD MILLION) 237
TABLE 265 EUROPE: OTHER FILTRATION TECHNIQUES MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 237
TABLE 266 ASIA PACIFIC: OTHER FILTRATION TECHNIQUES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 238
TABLE 267 LATIN AMERICA: OTHER FILTRATION TECHNIQUES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 238
TABLE 268 MIDDLE EAST: OTHER FILTRATION TECHNIQUES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 239
TABLE 269 GCC COUNTRIES: OTHER FILTRATION TECHNIQUES MARKET, BY COUNTRY 2022–2029 (USD MILLION) 239
TABLE 270 GLOBAL PHARMACEUTICAL FILTRATION MARKET, BY TYPE 2022–2029 (USD MILLION) 241
TABLE 271 GLOBAL STERILE FILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION) 242
TABLE 272 NORTH AMERICA: STERILE FILTRATION MARKET, BY COUNTRY 2022–2029 (USD MILLION) 242
TABLE 273 EUROPE: STERILE FILTRATION MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 243
TABLE 274 ASIA PACIFIC: STERILE FILTRATION MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 243
TABLE 275 LATIN AMERICA: STERILE FILTRATION MARKET, BY COUNTRY/REGION 2022–2029 (USD MILLION) 244
TABLE 276 MIDDLE EAST: STERILE FILTRATION MARKET, BY COUNTRY/REG